Semisynthetic and synthetic antibiotics


words: Antibiotics, medicine, E.coli, ?-lactam antibiotics, penicillin, cephalosporin, macrolides, fluoroquinolone, sulfonamide, tetracycline, aminoglycoside, antibiotic resistance, Streptomyces violatus.

In biotechnology, biologically active substances describes the beneficial or adverse effects of a drug <#"justify">Accordingly intention of course work offer to improvement of antibiotic production using Streptomyces vielatus by optimization of the cultural conditions.

Allow course work consist of four major part. First part (Analytical review) has material which described biotechnological production of antibiotics. Second part (Experimental part) discarded procedure of experiment with concrete description. Third part-is a part protection of workers and life safety. Fours part is about environmental conservation. In conclusion I have a concrete research and development work of biotechnological production of anntibiotics and improvement of antibiotic production using Streptomyces vielatus by optimization of the cultural conditions.


Normative referencesand notation


. Analytical review

1.1Antibiotics as representatives of BAS from microorganisms

1.1.1 Use of antibiotics in human, veterinary and plant medicine

1.1.2 Peptide and peptide-derived antibiotics

1.1.3 Genetic manipulation of antibiotic producers

1.1.4 Search for new antibiotics

1.1.5 Semisynthetic and synthetic antibiotics

1.2 Resistance to antibiotics

1.2.1 Regulation of antibiotic production

1.2.2 Influence of low molecular compounds

1.2.3 Reception of signals from environment

1.3 Technology of antibiotic production

1.3.1 Conservation of microorganisms

1.3.2 Isolation, separation and purification of antibiotics

. Experemental part

2.1 Abstract to Streptomyces violatus

.1.1 Producer of experiment

.2 Results and discusion

.2.1 Influence of some cultivation factors on the production of antibiotic

.2.2 Influence of nitrogen source

2.2.3 Influence of potassium phosphate and magnesium sulphate salts

.2.4 Influence of trace elements

3. Protection of workers and life safety

. Ecological conservation


Normative references

This course work refers to the following documents:

СТ РК 1.5 - 2004 General requirements for the construction, presentation, design and maintenance of standards СТ РК 1.14 - 2004 ГСС РК Standard of organization. Forms and procedure of developmentСТ РК 1.12 - 2000 Regulatory text documentsГОСО РК 3.08.327 - 2006State educational standards of RK. Higher education, professional. The main provisions.ГОСТ 2.105 - 95 ЕСКДGeneral requirements for textual documents.ГОСТ 2.106 - 96 ЕСКДTextual documents.ГОСТ 2.109 - 73 ЕСКДMain requirements to scheme.ГОСТ 21.1101 - 97 СПДСMain requirements to project and detailed documentation. СТ ЮКГУ 4.02-2010General requirements to scheme, statement and appearance of documentation of SMK.СМК ЮКГУ ПР 7.03-2012Management of learning and teaching processes.СМК ЮКГУ ПР 4.01 - 2012Management of documentationСМК ЮКГУ ПР 7.04 - 2012Academic studies. General requirements to the organization, contents and carrying out lessons.


Antibiotics - are defined as microbial products that inhibit growth of other microorganisms.

Secondary metabolites - are meant products of microorganisms (also plants) which are not essential for basic metabolic processes such as reproduction and growth.

Cephalosporins - a basic structure similar to that of penicillins and the derivatives are also formed by a variation of the side chain.

Tetracycline - is a broad-spectrum polyketide <#"justify">Actinobacteria - a group of Gram-positive bacteria with high G+C ratio. These organisms may be terrestrial or aquatic.

Antibiotic resistance - occurs when an antibiotic has lost its ability to effectively control or kill bacterial growth; in other words, the bacteria are "resistant" and continue to multiply in the presence of therapeutic levels of an antibiotic.

?-Lactam Antibiotics - a broad class of antibiotics that include penicillin derivatives (penams), cephalosporins (cephems), monobactams, and carbapenems, that is, any antibiotic agent that contains a ?-lactam nucleus in its molecular structure. - a genus of common Gram-negative, rod-shaped bacteria of the family Enterobacteriaceae. Negative Bacteria - refers to the inability of a microorganism to accept a certain stain. This inability is related to the cell wall composition of the micro-organism and has been useful in classifying bacteria.

Diminution and notation

cycliv AMP receptor proteinactinorhodincalcium-dependent antibioticsundecylprodigiosionantimicrobal peptides biotechnology

NADP- nicotinamide adenine dinucleotide phosphate <>rhodopseudomonas copsulata deoxyribonucleic acid riboxyribonucleic acid


Timeliness.The mass production of antibiotics began during World War II with streptomycin and penicillin. Now most antibiotics are produced by staged fermentations in which strains of microorganisms producing high yields are grown under optimum conditions in nutrient media in fermentation tanks holding several thousand gallons. The mold is strained out of the fermentation broth, and then the antibiotic is removed from the broth by filtration, precipitation, and other separation methods. In some cases new antibiotics are laboratory synthesized, while many antibiotics are produced by chemically modifying natural substances; many such derivatives are more effective than the natural substances against infecting organisms or are better absorbed by the body, e.g., some semisynthetic penicillins are effective against bacteria resistant to the parent substance.

Despite the wide variety of known antibiotics, less than 1% of antimicrobial agents have medical or commercial value <#"justify"> The purpose of my research is improvement of antibiotic production using Streptomyces vielatus by optimization of the cultural conditions.

Basic part

1. Analytical review

.1 Antibiotics as representatives of biologically active substances from microorganisms

Antibiotics are defined as microbial products that inhibit growth of other microorganisms. After the antibiotic effect of penicillin had been observed by Fleming, a number of other antibiotics were discovered. The main producers are soil microorganisms as actinomycetes moulds anf fungi. New antibiotics being searched for the microorganisms were found to produce a broad spectrum of compounds having various effects on living organisms. Some of them have occupied a weighty position as medicines and agricultural drugs and for animal health. One microorganism can produce several compounds with different biological activity (staurosporine) and, on the contrary, one compound can be produced by several microorganisms. Besides to traditional antibiotics, compounds with different biological activities are synthesized by various microorganisms: coccidiostatics used in poultry farming, antiparasitic compounds with a broad spectrum of the activity against nematodes and arthropods, substances with the antitumor activity, immunosuppressors, thrombolytics (staphylokinase), herbicides, pesticides, compounds affecting blood pressure, etc [2].

For medicine are important enzyme inhibitors synthesized by microorganisms. They are used as inhibitors of enzymes produced by resistant strains that decompose the antibiotic during application of antibiotics. These enzyme inhibitors can be also used for inhibition of undesirable enzyme activities in human metabolism that cause some illnesses. Many enzyme inhibitors are protease inhibitors, variously active against pepsin, papain, trypsin, chymotrypsin, catepsin, elastase, renin, etc. Inhibitors of glucosidases, cyclic AMP phosphodiesterase, different carbohydrases, esterases, kinases, phosphatases, etc. have been isolated from microorganisms. The enzyme inhibitors that participate in the biosynthesis of cholesterol and fat are also used in medicine.

Several thousands of compounds having different biological activities have so far been listed and new compounds are still isolated from microorganisms. There is a widespread acceptance that microorganisms are an unlimited source of new substances with many potential therapeutic applications. A great number of those compounds, however, are toxic and thus cannot be used for human and veterinary therapy.

Role of antibiotics in producing microorganisms.Antibiotics are the typical secondary metabolites produced by microorganisms. Secondary metabolites are meant products of microorganisms (also plants) which are not essential for basic metabolic processes such as reproduction and growth [3]. On the other hand, in the case of many secondary compounds, pieces of evidence of their role in the metabolism of the producer have been brought. These compounds often function as the so-called signal molecules, used to control the producers metabolism. One of the functions attributed to antibiotics is a suppression of the competing microorganisms in the environment. Thus the antibiotic-producing microorganisms have an advantage in competing for nutrients with the other microorganisms but antibiotic activity is only one from many other biological activities of secondary microbial products. However, the function of antibiotics in the environment can be observed only with difficulty.

1.1.1 Use of antibiotics in human, veterinary and plant medicine

Antibiotics are very often used in medicine for suppression of pathogenic bacteria, fungi and viral diseases. Their use marked a revolution in medicine, saved millions of lives and helped reduce some, rather frequent diseases such as tuberculosis. An efficient, antiprotozoan antibiotic, however, has not yet been discovered. Antibacterial antibiotics are sometimes used in the case of viral diseases to protect the weakened macroorganism against a subsequent bacterial infection. As mentioned in the introductory part, some antibiotics are also used as cancerostatics or for curing some other illnesses.a similar way as in human medicine, antibiotics are also employed in veterinary medicine. Besides, antibiotics are added to various feeding mixtures used in poultry and animal farming to keep the animals in good health. If the antibiotics are used, higher farming yields are often reached. However, the administration of antibiotics should be stopped a certain time before the animal is slaughtered and the meat consumed since the residues of antibiotics should not enter the human diet. To avoid the production of strains resistant to the antibiotics used in human medicine, special antibiotics allowed to be employed in veterinary medicine and animal production have been singled out and are no more used in human medicine (chlortetracycline, bacitracin, tylosin, etc.).

Side effects of antibiotics.In addition to their positive effects, antibiotics can also have negative effects. Besides various allergies linked with the use of antibiotics, the human organism can sometimes suffer a damage when treated with them. Sometimes toxic compounds can be formed when antibiotics are transformed in the organism. Tetracyclines, that form complexes with calcium, can, for example, inflict damage on the formation of tooth enamel in children, on the condition they are frequently used during the period of teeth growth. A number of newly discovered antibiotics cannot be used for therapy because of their excessive toxicity. Fortunately, the first antibiotic to be used on a massive scale, penicillin, has relatively moderate side effects on the human organism..In spite of variety of their structures, antibiotics are synthesized from simple building units amino acids, acetate, propionate, sugars, nucleotides which are used in living organisms for the biosynthesis of cellular structures. According to their structure and type of biosynthesis, antibiotics are classified to form several groups.

1.1.2 Peptide and peptide-derived antibiotics

Peptides.Microorganisms produce a number of peptides that have the biological activity. In contrast to biologically active peptides of higher organisms, where they function as hormones, the function of microbial peptides in microorganisms is not known. They are included in the group of secondary metabolites. They differ from the biologically active peptides of higher organisms in having often D-amino acids in their molecules. Besides their antibiotic activity, another interesting feature of the peptide antibiotics is the fact that they are not synthesized on ribosomes, as other peptides, but on enzyme complexes called peptide synthetases [3-4].

Chemical structure. Amino acids linked by the peptide bond form the basal structure of any peptide antibiotic. The peptide chain is often cyclic or branched. In addition to L-amino acids, other compounds can also be present in the molecule, such as D-amino acids, organic acids, pyrimidines and sugar molecules. Numbers of derivatives are known to exist in the case of some peptide antibiotics, that differ in both amino acid substitutions and substituents bound to the amino acids.

The linear molecule of gramicidin A and the cyclic molecule of gramicidin S belong to the structurally simplest peptide antibiotics. Bacitracins are an example of cyclic peptides having a side chain (Fig. 2). In the molecule of bleomycins, the sugars L-glucose and 3-O-carbamoyl-D-mannose are found. Peptide antibiotics containing an atom of iron or phosphorus in the molecule have also been isolated. If two molecules of cysteine are present in the peptide antibiotic, they are linked by a sulfide bridge. Another cyclic polypeptide (heptapeptide) is iturin, an antifungal antibiotic, produced by Bacillus subtilis, effective against plant pathogens [4].

A special type of compounds are enniatines. Their molecule consists of three residues of branched amino acids, L-valine, L-leucine and L-isoleucine, and three residues of D-2-hydroxyisovaleric acid (D-Hyiv). The amino acids and D-Hyiv are linked by alternating amide and ester bonds. The amide bonds are finally N-methylated.. The biosynthesis of peptide antibiotics takes place on a multienzyme complex [5]. The individual amino acids are activated using ATP to form aminoacyl adenylates. The aminoacyl groups are transferred to the enzyme thiol groups where they are bound as thioesters. The structural arrangement of the thiol groups in the synthetases determines the order of amino acids in the peptide. The formation of peptide bond is mediated by 4-phosphopantetheine, that is an integral part of the multifunctional multienzyme.

The way how the order of the amino acids in the molecule is regulated is not known. It is probably determined by the tertiary configuration of the enzyme. This specificity, however, is not very high since the microorganisms mostly produce a mixture of peptides differing only in one or several amino acids in the chain.. Gramicidin S synthetase is an enzyme consists of two complementary enzymes having molecular weights of 100 kD and 280 kD.synthetase. The enzyme consists of three subunits having molecular weights of 200, 210 and 360 kD [5]. Each subunit contains phosphopantetheine. The enzyme A activates the first five amino acids of bacitracin, the enzyme B activates L-Lys and L-Orn, and the enzyme C activates the other five amino acids. D-amino acids are produced by racemization of their L-forms directly on the enzyme complex. Initiation and elongation start on the subunit A up to the pentapeptide, independently of the presence of the subunits B and C. The pentapeptide is transferred to the subunit B where two other amino acids are added. The heptapeptide is subsequently transferred to the subunit C where the biosynthesis of bacitracin is finished. The cyclization is achieved by binding the asparagine carboxy group to the ?-amino group of lysine, whereas, to the ?-amino group of the same lysine, the isoleucine carboxyl group is bound.of action. The antibiotic activity of bacitracin results in an efficient inhibition of proteosynthesis and cell wall synthesis but other effects such as an interference with cytoplasmic membrane components and cation-dependent antifungal effects have been observed as well. In the case of gramicidin S, hemolytic effects, inhibition of protein phosphatases and interaction with nucleotides have been observed, in addition to the antibacterial activity. Even though antibiotics normally have several mechanisms of their action, the primary one is thought to be the effect observed at the lowest concentration of all. The peptide antibiotics are efficient mainly against Gram-positive bacteria

ß-Lactams.The main representatives of ß-lactams are penicillins and cephalosporins. Penicillins have a thiazoline ß-lactam ring in the molecule and differ, one from another, by side chains linked via the amino group.

Cephalosporins [6] have a basic structure similar to that of penicillins and the derivatives are also formed by a variation of the side chain.

The thiazolidine ß-lactam ring is synthesized using three amino acids: L-?-amino adipic acid, L-cystein and L-valine by ?-aminoadipyl-cysteine-valine synthetases . By condensation of these three amino acids, a tripeptide is formed. It is transformed to the molecule of penicillin or cephalosporin through subsequent transformations. The principial works about enzymes of ?-lactams biosynthetic pathways were done by Abraham and his collegues.

Clavulanic acid also belongs to ß-lactams . This acid has a bicyclic ring structure resembling that of penicillin, except that oxygen replaces sulfur in the five-membered ring. Clavulanic acid is an irreversible inhibitor of many ß-lactamases. The discovery of clavulanic acid was a starting point for the development of penicillin analogues, able to inactivate these enzymes.activity. Penicillins are especially active against Gram-positive bacteria but some semisynthetic penicillins, such as ampicillin, that is lipophilic as compared to, for example, benzyl penicillin, are also effective against Gram-negative bacteria. This effect is explained by their easier entering the cells of Gram-negative bacteria that have a high lipid content in the cell wall. ß-lactam antibiotics interfere with the synthesis of bacterial cell wall and thus inhibit bacterial growth. Such a mechanism of action does little harm to the macroorganism to which ß-lactams are applied.

Glycopeptides.present several hundreds compounds belonging to glycopeptides are known, including semisynthetic derivatives. The best known of all is vancomycin [20] that is effective against Gram-positive bacteria. This antibiotic is widely used in medicine, especially against ß-lactam resistant microorganisms. Vancomycin is not absorbed from the gastrointestinal tract and is used to treat enterocolitis caused mainly by Clostridium difficile.

Vancomycin is produced by several tens of microorganisms, of which Amycolotopsis orientalis is used for commercial production. Glycopeptides are composed of either seven modified or unusual aromatic amino acids or a mix of aromatic and aliphatic amino acids.

Polyketide-derived antibiotics.A large group of antibiotics includes compounds that are synthesized by polymerization of acetate units and subsequent cyclization of the polyketo chain, that has been formed before or is just being formed, to provide six carbon atoms containing aromatic rings or macrocyclic lactone ring. The terminal group need not be an acetate but also pyruvate, butyrate, ethyl malonate, paraminobenzoic acid, etc. In the early phase, the formation of polyketo chain is similar to that taking place during the biosynthesis of fatty acids, and is catalyzed by the enzyme polyketosynthase. A principal role is played by the Acyl Carrier Protein (ACP) [7]. The ACP prosthetic group in many microorganisms is 4´-phosphopantothenic acid. Its terminal groups and acyls produced by polymerization are bound via the -SH group. The acyls are transferred to the other -SH group, that is a part of the cysteine molecule. Polyketosynthase has not yet been isolated and its properties have been deduced from the analyses of DNA sequences of cloned genes. Polyketosynthases include two distinct groups located either in domains on multifunctional proteins or present on individual, monofunctional proteins.

6-Methyl salicylic acid.6-Methyl salicylic acid (6MS) represents the simplest polyketide, that is formed by condensation and subsequent aromatisation of one acetylCoA molecule and three malonylCoA molecules. This compound was isolated from Penicillium patulum. By other metabolic steps 6MS is transformed to produce a toxin called patulin. The synthesis of 6MS takes place on an enzymatic complex called 6MS synthetase [7-8].

Tetracyclines. Chlortetracycline and tetracycline are produced by the actinomycete Streptomyces aureofaciens, whereas oxytetracycline and tetracycline by the actinomycete Streptomyces rimosus. The tetracycline molecule is synthesized from one molecule of malonic acid semiamide and eight molecules of malonate. In the early steps, the synthesis is similar to the biosynthesis of fatty acids, but the keto groups are not reduced and aromatic rings are formed to yield 6-methyl pretetramide. This compound is the first known intermediate of the tetracycline biosynthesis that is further transformed to yield one of the tetracycline molecules. As to the enzymes transforming the intermediates of chlortetracycline and tetracycline biosynthesis, the last three have been described: S-adenosylmethionine:4-dedimethylamino-4-aminotetracycline N-methyltransferase methylating the amino group in position 4, anhydrotetracycline oxygenase and NADP:tetracycline 5a(11a)dehydrogenase (tetracycline dehydrogenase). For more extensive coverage of research, articles by B?hal and B?hal and Hunter [8] can by consulted.act as inhibitors of proteosynthesis. They are considered to be wide-spectrum antibiotics, that are efficient against both Gram-positive and Gram-negative bacteria. However, having significant side effects on the human macroorganism, they are preferably used only in the case other, less toxic antibiotics are not effective.

Anthracyclines.Anthracyclines are synthesized in a similar way as other polyketides. They often have one or several sugar residues in the molecule, most often deoxy-sugars, synthesized from glucose, are present in the anthracycline molecule. As to their biological activity, daunorubicin and doxorubicin (adriamycin) are rather important. They are excellent antitumor agents, which are widely used in the treatment of a number of solid tumors and leukemias in human. However, these drugs have dose limiting toxicities such as cardiac damage and bone marrow inhibition. In recent years, a variety of drug delivery systems for anthracyclines have been reported. In most cases, the drugs were linked to high molecular compounds such as dextran , DNA and others.

Macrolides and polyenes.Macrolides are usually classified to include: proper macrolides having 12-, 14- or 16-membered macrocyclic lactone ring to which at least one sugar is bound, and polyenes having 26- to 38-atom lactone ring containing 2 to 7 unsaturated bonds. Besides the sugars bound to the lactone ring, an additional aromatic part is normally present in the polyene molecule. As to the biosynthesis, however, both macrolides and polyenes are synthesized in the same way using identical building units.represent a broad group of compounds and new substances have been incessantly added to the list, including hybrid compounds. A number of derivatives of the basic structure can be produced by one microorganism, on the other hand, however, the compounds can also be found in different microorganisms. Macrolides usually possess an antibacterial activity whereas polyenes are mostly fungicides.produced by Saccharopolyspora erythrea, together with oleandomycin and picromycin, belong to the best known 14-membered lactone ring macrolides. A novel erythromycin was prepared by the recombinant Saccharopolyspora erythrea strain [9]. Macrolides with a 16-membered ring are represented by tylosin, that is produced by Streptomyces fradiae, as well as by leucomycin, spiramycin, etc. synthesis of lactone ring is similar to that observed in the case of other polyketides. In contrast to aromatics, propionate and butyrate units are more often used in the biosynthesis, instead of acetate ones. The greatest difference, however, consists in the fact that, instead of aromatic rings, a lactone ring is formed. Keto- and methyl groups of the polyketide chain, from which macrolides are formed, are normally transformed more frequently.Nystatin is the best known polyene antibiotic. Candicidine is another well known antibiotic belonging to the polyene group. Its molecule includes p-aminoacetophenone as the terminal group. 4-amino benzoic acid (PABA) was identified as a precursor of the aromatic part of candicidine molecule.

The sugars found in macrolide and polyene molecules are not encountered in the structures of microbial cells. They include both basic and neutral sugar molecules. Often, L-forms are found. Sofar, at least 15 different sugars have been described to occur in macrolides and polyenes. All of them are 6-deoxy sugars; some of them are N-methylated, others have the methyl on either the oxygen or carbon atom. As it has been repeatedly proven , glucose is primarily incorporated into macrolide sugar residues. Also in Streptomyces griseus, glucose, mannose and galactose were incorporated to a greater extent into the mycosamine candicidine, as compared to its aglycon . The transformation of glucose to a corresponding sugar takes place in the form of the nucleoside diphosphate derivatives, which is similar to the situation found in the case of other antibiotics.

Avermectins.The molecule of avermectins [10] consists of a 16-membered, macrocyclic lactone to which the disaccharide oleandrose is bound (Fig. 15). Avermectins are produced by Streptomyces avermitillis. The macrocyclic ring of avermectins is synthesized, as other polyketides, by producing a chain from acetate, propionate and butyrate building units. Oleandrose (2,6-dideoxy-3-O-methylated hexose) is synthesized from glucose.

Avermectins are potent antiparasitic compounds with a broad spectrum against nematode and anthropod parasites. They lack antifungal and antibacterial activities. They bind to a specific, high-affinity site present in nematodes but not in vertebrates. Its dosage for animal and human is extremely low. Ivermectin (22,23-dihydroavermectin B1) is a semisynthetic compound which is used to control internal and external parasites in animals. It is the most potent anthelmintic compound of all. Avermectins are also employed in human medicine and plant protection. Detailed reviews on the uses and biosynthesis of avermectins can be found in recent monographs.

Chloramphenicol.Chloramphenicol is produced by Streptomyces venezuelae [11]. However, at present the antibiotic is commercially produced using a fully synthetic process. In contrast to polyketides, the aromatic ring of chloramphenicol molecule is synthesized from glucose via chorismic acid and p-amino benzoic acid in the microbe.

Aminoglycosides.Streptomycin (Fig.4) is a well-known representative of aminoglycoside antibiotics. It is synthesized by many streptomycetes to produce a number of derivatives. The molecule of streptomycin consists of three components: streptidine, L-streptose and N-methyl-L-glucosamine. None of these components has been found in the primary metabolism of microorganisms. The biosynthesis of streptomycin was disclosed mainly by Walker [12], who also studied the enzymes participating in the biosynthesis of streptomycin .

The importance of streptomycin consists mainly in its efficiency to suppress Mycobacterium tuberculosis. A massive use of streptomycin resulted in effective suppression of tuberculosis, especially in developed countries. Recently, however, the disease caused by M. tuberculosis has been found to increase again due to the occurrence of strains resistant to streptomycin.

Antiviral compounds.Recently also compouds active against viruses have been discovered. Sattabacins and sattazolins, isolated from Bacillus sp. and fattivirin A1, isolated from Streptomyces microflavus are active against Herpes simplex viruses. Inhibitors of HIV are intensively looked out in microorganisms. Inhibitors of HIV-1 protease were detected in fungus Chrysosporium merdarium P-5626. A compound which has an inhibitory effect on HIV-1 replication in chronically infected cells as well as actualy infected cells was isolated (after screeninng 10,000 microorganism products) from the culture supernatant of Streptomyces sp. Mer-2487. A hydroxyl benzaldehyde compound, active against influenza virus in vitro, was isolated from Aspergillus terreus. Rhodopseudomonas capsulata produces a virucide substance which inactivated polio virus, Sindbis virus, some fish viruses, without causing any damage to the host cells.

1.1.3 Genetics production strains.The genes coding the enzymes that synthesize antibiotics are mostly located on chromosomes. These genes are called structural genes and the enzymes taking part in the antibiotic synthesis are called the enzymes of secondary metabolism. The structural genes are organized to form one cluster. This situation has been observed in all cases described so far. The expression of structural genes is controlled in a similar way as in the case of other genes. Next to a cluster of the structural genes, the genes coding for the resistance of the producer to its own antibiotic are located. Those genes are situated either at the beginning or at the end of the cluster, often in both positions. In the case the resistance genes are present in the two positions, different types of resistance are included as a rule. In addition to the structural genes, regulation genes also determine the antibiotic production. They are often located on plasmids. The genetic control of antibiotic biosynthesis is poorly known. The type of control where the antibiotic synthesis is inhibited by the own product can serve as an example. As a result, the products cellular concentration is maintained at a physiologically tolerable level and, consequently, the producing microorganism is prevented from being self damaged by high concentrations of the product, that are toxic.

Multiplication of the structural genes is not an important factor increasing the antibiotic production. Mutations resulting in an increased antibiotic synthesis mostly affect the regulatory genes. Hopwood and co-workers [12-13] transferred the genes for the production of actinorhodine to a low production, wild type strain using a plasmid. Even though the number of copies of the structural gene increased only twofold, the production of the antibiotic rose 30-40 times. The increase of the antibiotic production has to be accompanied by an increase of resistance to the own product.

When high production strains are prepared by mutagenesis, a type of mutant that loses some of the structural genes can also be obtained. Such a mutant can exhibit a higher level of an antibiotic intermediate whose transformation stopped due to the absence of the corresponding enzyme. By crossing these mutants, some biosynthetic pathways used to synthesize antibiotics were elucidated, e.g. tetracyclines .Genetic manipulation of antibiotic producers.The structural genes for a number of antibiotics have been cloned into host microorganisms. Similarly, genes for antibiotic resistance and other regulatory genes have also been cloned. Streptomyces lividans was found to be a suitable acceptor of foreign genetic material, in which a low degree of restriction of this genetic material exists. This microorganism can host various plasmids and phage vectors. However, at the same time, this microorganism was found not to be usable for the synthesis of various antibiotics or of high antibiotic levels. The antibiotic biosynthesis is a very complex process that requires not only the structural genes for enzymes of secondary metabolism but also the genes for regulation of their biosynthesis. Moreover, the overproduction of an antibiotic has to be coordinated with the primary metabolism of the producing microorganism.

Polyketide synthase genes of microorganisms producing various polyketides have also been hybridized. As a result, a great similarity of polyketide synthases from various streptomycetes was evidenced and new polyketide antibiotics were synthetized.

.1.4 Search for new antibiotics

Isolation from nature.At present several thousands of compounds having some biological activity have been obtained from microorganisms isolated from nature. As the probability of finding a new compound that would be usable as a new antibiotic is as little as one in ten thousand, a great number of microorganisms have to be checked. A rough estimation says that about 100 000 microorganisms is screened for the presence of biologically active compounds per year. Well equipped laboratories study about 30 different biological activities. The requirements for new antibiotics result from the occurrence of resistant strains of pathogenic microorganisms, that are no more sensitive to known antibiotics used in the clinical practice. It is mostly big pharmaceutical companies that look for new antibiotics. Their search for new compounds is highly automated. The selection methods used and the methods of detection of the biological activity are normally not published.

Preparation of a new antibiotic and its introduction into the clinical practice requires cooperation of scientists from various scientific disciplines. They can be divided into three groups : microbiology (colection of source samples, isolation of diverse microbes, fermentation to enhance the production, taxonomy), pharmacology (target selection, screen design, high-troughput screening, identification of active compounds, efficacy studies, mechanism of action), chemistry (active compounds identification, characterization/replication, isolation/purification, structure elucidation). Producers of antibiotics and other biologically active compounds.The majority of the known antibiotics are produced by actinomycetes, fungi and by moulds. With an increasing spectrum of efficiency of microbial metabolites, new, non-traditional sources of such compounds have been looked for. Tropical soils have an enormous biodiversity and they are a rich source of new antibiotics [14].

The tests of other biological than antibiotic activities require sophisticated methods. This is true especially when enzyme inhibitors are looked for. Thus, Ogawara chose a tyrosine protein kinase associated with the malignant transformation of the cell caused by retroviruses as the target in a biochemical screen and found genistein, an isoflavone from Pseudomonas, exhibiting a specific inhibitory activity. Production of target enzymes using recombinant DNA methodology has dramatically expanded the number of potential targets that can be feasibly screened. A screen for the inhibitors of HIV reverse transcriptase is an example. The enzyme was produced in Escherichia coli, purified by affinity chromatography, and used to test natural products for the activity.

1.1.5 Semisynthetic and synthetic antibiotics

After the structures of the antibiotics discovered had been determined and microbial strains resistant to them detected, possible variations of the molecules of known antibiotics were studied. Several methods have been used to accomplish such variations.

Biosynthetic antibiotics. unspecificity of the enzyme systems able to synthesize antibiotics was used, together with the addition of precursors to the growth medium. Thus, the reaction equilibrium was shifted to promote the production of the derivative required. In this way, penicillins with different side chains were prepared. Addition of amino acids to the growth medium can affect the amino acid composition of polypeptide antibiotics. The individual derivatives of penicillin and cephalosporin have slightly different antimicrobial spectra and are capable of suppression of microorganisms resistant to other derivatives.

Semisynthetic antibiotics.of a part of the antibiotic molecule can be accomplished chemically or enzymatically. In this way, semisynthetic penicillins, cephalosporins, tetracyclines, etc. were prepared. The production of semisynthetic penicillins and cephalosporins was facilitated by the fact that 6-amino penicillanic and 7-amino cephalosporanic acids (Fig. 18) could be easily prepared. The side chain is removed by the action of an enzyme or by a chemical hydrolysis and to the amino group in position 6 (penicillins) or 7 (cephalosporins), that was made free in the previous step, another acyl is bound chemically or enzymatically. In such a way, various penicillins and cephalosporins have been prepared to be effective against microorganisms resistant to original compounds.tetracyclines, pyrolinomethyltetracycline, metamycin and doxycycline, exhibit a greater solubility and somewhat different antimicrobial spectrum, as compared to the original tetracyclines [15]. New derivatives of aminoglycosides have been obtained by chemical and enzymatic modifications.synthesis of antibiotics.As the majority of antibiotics have rather complex structures, their chemical synthesis is mostly more expensive than the production by fermentation. An exception to the rule seems to be chloramphenicol, that is normally prepared using a chemical synthesis.

Hybrid antibiotics.Using of genetic engineering we can combine structural genes of different antibiotic producers to obtaining new products which are not present in nature . If these genes are expressed, a hybrid antibiotic is synthesized, that cannot be found in nature. Hopwood et al. [16] used this method with the genes of actinorhodin synthesis and obtained related hybrid macrolides, mederhodin A and B, dihydromederhodin A and dihydrogranatirhodin. Niemi et al. [16] prepared new anthracyclines by combination of DNA Streptomyces purpurascens.

.2 Resistance to antibiotics

The antibiotic resistance is usually looked at from two angles: first, how the microbial strains arise, that obtain the resistance during the treatment of the macroorganism with the antibiotic, second, the resistance of microorganisms producing antibiotics that build up their resistance against the product of their own which, synthesized at high concentrations, would damage the producer. The ways of how these two types of resistance are achieved are often similar, even though the aims are different. Whereas a resistant microorganism is most often capable of transforming the antibiotic or even degrading it completely, the resistance of producing microorganisms has to ensure that the antibiotic will not be destroyed.

Resistance of antibiotic producers. The basic metabolic processes of microorganisms producing antibiotics are not inhibited, if the antibiotics are synthesized at low concentrations, observed in strains isolated from nature. By strain improvement, mutants have been able to reach 100 to 1000-fold antibiotic yields, as related to a volume unit of the fermentation medium. Genome changes of the improved strains include a number of deletions and amplifications in the chromosomal DNA. Changes in extrachromosomal DNA were also detected.

Low production strains, whose resistance to the own product is low (i.e. higher concentrations of the product inhibit their growth), regulate the antibiotic production, e.g. by inhibiting the enzyme activities that participate in the synthesis of the antibiotic. In high production strains, such a control is lost and the strains have to find a way how to survive in the presence of a high concentration of the antibiotic without decomposing it.As mentioned above, the genes for resistance to the own product are often located at the beginning of the cluster of structural genes. As a result, they are expressed simultaneously with the structural genes. However, the genes of newly gained resistances are mostly located on plasmids. Many antibiotics inhibit protein synthesis, the target site being at the ribosome level. Often, the functions of Tu and G elongation factors are also impaired, together with the synthesis of guanosin penta- and tetraphosphates that is significantly reduced. The antibiotic producers (mostly actinomycetes), as well as the bacteria against which the antibiotic is used, protect themselves by posttranscriptional modification of rRNA. Adenine is methylated to obtain N6-dimethyladenine rRNA in 23S. Such modified ribosomes do not bind the antibiotic. In other cases, adenine is methylated to yield 2-O-methyladenosine.

The most important mechanism of resistance observed in the antibiotic producers seems to be the transport of the antibiotic from the cell to the environment. In the case of high production rates, probably no protection of the active centres could be sufficiently effective. In addition, the antibiotic produced would gradually fill up the interior of the cell. In Streptomyces rimosus, an oxytetracycline producer, genes for the enzymes increasing the antibiotic transport rate precede the structural genes on the chromosome. Genes for the resistance consisting in the protection of ribosomes via the synthesis of an unidentified protein are located at the end of the structural gene cluster [17].

Antibiotic producers also have to solve the problem of a reverse flow of the antibiotic into the cell. Some antibiotics bind to the cell wall, others are complexed in the medium (tetracyclines in the presence of Ca2+ ions). Cytoplasmic membranes of resistant strains are often less sensitive to the effect of antibiotics. This kind of resistance is thought to be connected with the content of phospholipids in the cell. In Bacillus colistinus, a colistin producer, the content of phospholipids in the cell-free extract increased with the sensitivity to the antibiotic.Another way how the antibiotic producers can avoid the effect of their products is by situating the distal enzymes of the antibiotic biosynthetic pathway (synthases) outside the cell, most often in the periplasm. In Streptomyces aureofaciens, a higher proportion of the outside terminal tetracycline synthase was found in production strains under high production conditions in periplasm, as compared to low production conditions [18].

Resistance in pathogenic microorganisms.Shortly after antibiotics were introduced into clinical practice on a massive scale, strains of hitherto-sensitive microorganisms started to appear, that required the use of much higher antibiotic concentrations or, even, were completely resistant to these antibiotics. The resistant strains originated from clones that survived the antibiotic treatment, especially if the treatment was terminated before all pathogenic microorganisms were killed or the antibiotic was applied at sublethal doses. There are several ways how microorganisms can gain resistance .In most resistant microorganisms, the main mechanisms of resistance are detoxification or inactivation of the antibiotic, change of the target site, blocking of the transport of the antibiotic out of the cell.

Penicillins and cephalosporins are degraded using three ways:) by the enzyme penicillin amidase that cleaves the amidic bond by which the side chain is bound to the ?-lactam ring,

b) by the enzyme acetyl esterase that hydrolyzes the acetyl group at C-3 on the dihydrazine ring of cephalosporins,) by the enzyme ?-lactamase that catalyzes hydrolysis of the ?-lactam ring of penicillins and cephalosporins.Penicillin amidases are rarely used by microorganisms to build up resistance to ?-lactam antibiotics. They are often employed for the synthesis of semisynthetic antibiotics. Acetyl esterase is also not important from the point of view of antibiotic resistance. In most cases, ?-lactam antibiotics are inactivated by ?-lactamase that destroys one of the important sites for their antibiotic activity; the damage is irreversible.

1.2.1 Regulation of antibiotic production

Overproduction of secondary metabolites.Microorganisms produce in natural environment only small amount of antibiotics. They have to control the antibiotic synthesis since secondary metabolites at high concentrations are mostly toxic even for their producers. Using high-yielding strains and optimization of fermentation condition we can reach many times higher production. In that case we speak about "overproduction" . Production of antibiotics in factories are at present several thausands higher as production of original strains isolated from nature but this high production is reached only when high-yilding strain is used and special conditons of cultivation are kept. The main factors influence production of antibiotics are discused in next chapters. phases of microbial culture.A culture of a microorganism capable of antibiotic production, where the overproduction of the antibiotic is taking place, includes several growth phases representing a number of physiological states.

Preparatory phase (lag phase) - the culture is adapting to the new environment, the growth is slow and, evidently, regulatory proteins are being synthesized that, on the basis of the information from the environment, activate the expression of the respective genes during cultivation.phase - the culture grows intensively, usualy a low amount of antibiotic is synthesized.phase - growth rate and proteosynthesis slowed down; the antibiotic production is started. The enzymes of secondary metabolism are intensively synthesized .phase - growth is practically ceased, dry weight of microorganism is constant, the antibiotic is intensively synthesized. producers mostly belong to filamentous microorganisms, which means that, in their culture, cells of various age and at different stages of development are present. The microorganisms grow in pellets, inside which the cultivation conditions differ from those on the pellet surface (nutrient concentrations, oxygen concentration, etc.). An increase in dry weight does not have to always mean the biomass growth since, in streptomycetes, often a thickening of the cell wall or glycocalyx formation occur that increase the dry weight value without rising the cell number . The individual cells can thus be at different stages of development, i.e. in different physiological states. Therefore, we speak about a physiological state of the whole culture that represents an average of physiological states of the individual cells.

Regulation by nutrients. In order to reach a high production of an antibiotic, a sufficient biomass yield is necessary, that is accomplished within a short time, if possible. Thus a danger of contamination is diminished and the economic parameters of the fermentation device are kept at its optimum. For this purpose, readily utilizable carbon, nitrogen and phosphorus sources are used. When they are present in the medium, however, an overproduction of the antibiotic does not take place. The culture medium should be designed in such a way that, after the biomass increased sufficiently, at least one of the basic nutrient sources would become depleted and the culture growth would be consequently limited. However, this limitation is not well understood.

Regulation by nitrogen source.Readily utilizable nitrogen sources present in the culture medium inhibit the production of antibiotics. Mainly ammonium ions decrease the antibiotic synthesis and, therefore, their concentration in the production media is limited to be exhausted at the end of growth phase. Soy flour, peanut flour and other complex substances are used as nitrogen sources in the production phase of antibiotic fermentations. These nitrogen sources are not easily utilizable and are similar to those used by the microorganisms producing antibiotics in nature. Readily utilizable nitrogen sources repress enzymes of secondary metabolism in Cephalosporium acremonium during the biosynthesis of cephalosporin and in Streptomyces clavuligerus producing cephamycin. Similarly, the inhibition of biosyntheses of leucomycin, tylosin , and erythromycin are explained by the repression of enzymes of secondary metabolism. Ammonium salts also inhibit the activity of anhydrotetracycline oxygenase isolated from S. Aureofaciens.

Regulation by phosphate[19]. Phosphate is used as main regulator of overproduction of antibiotics in factories. Inorganic phosphate is carefully added in doses to the medium so as to accomplish an optimal ratio between the biomass production and the capability of antibiotic biosynthesis. Bound to organic compounds normally added to the medium (soy flour, etc.), phosphate does not affect the antibiotic production. The antibiotic biosynthesis is started on the condition the concentration of phosphate in the medium decreased below a certain level. influence of inorganic phosphate is explained by repression of the synthesis of enzymes of secondary metabolism . After the inorganic phosphate was depleted from the medium, a significant decrease of the rate of proteosynthesis was observed during the tetracycline biosynthesis and the synthesis of enzymes of secondary metabolism was commenced. If phosphate was kept above the threshold concentration, the significant decrease of the rate of protein synthesis did not occur and enzymes of secondary metabolism were not synthesized. An addition of phosphate to the medium at the beginning of the production phase, after the phosphorus source was depleted and the enzymes of secondary metabolism synthesis initiated, resulted in a decrease of the enzyme levels in the culture and an acceleration of proteosynthesis. The synthesis of secondary metabolism was resumed after the phosphate was depleted again from the medium. Production of oxytetracycline by Streptomyces rimosus is controlled, at least in part, at the level of transcription from promoters overlapped by tandem repeats similar to those of the DNA-binding sites of the OmpR family [20]. The phosphate was found to be consumed at a higher rate than expected, with respect to the actual rate of protein synthesis, and was probably deposited in the cells in the form of polyphosphates.

.2.2 Influence of low molecular compounds

The antibiotic production can be regulated by different low molecular compounds. The mechanism of their action is not understood. Tryptophan exhibited a stimulatory effect on the production of antibiotics, e.g. mucidin in the basidiomycete Oudemansiella mucida and actinomycin in Streptomyces parvulus. Methionine was found to promote the synthesis of cephalosporin C. Neither tryptophan nor methionine were used as the building units. When enzymes of secondary metabolism were measured, higher levels were detected in the cells of the producing strain.Benzyl thiocyanate increases the production of chlortetracycline and tetracycline in S. aureofaciens. In contrast, it does not influence the production of oxytetracycline in S. rimosus. The effect on the metabolism of S. aureofaciens is multiple, including a number of enzymes but the basic influence of benzylthiocyanate at production is the higher expresion of enzymes of secondary metabolism. This is the reason why benzyl thiocyanate is able to raise the antibiotic production only if it is added in the lag phase, growth phase or at the beginning of the production phase. Its effect is more pronounced in low production strains, where the enzymes of secondary metabolism level and the antibiotic production are increased 10 to 20-fold, as compared to high production strains where the increase is only twofold. the streptomycete antibiotic producers, low-molecular, diffusible compounds have been discovered that regulate the metabolism of the producer, where they are present at very low concentrations, and thus affect both the biochemical and morphological differentiation. The most famous of them is factor A, gamma-butyrolactone, that was discovered in Streptomyces griseus producing streptomycin . A non-producing strain started the synthesis of streptomycin after factor A was added to the culture and, in parallel, the formation of aerial mycelium was taking place. Factor A is synthesized by many streptomycetes but the regulatory effect was observed only in Streptomyces griseus, Streptomyces bikiniensis and Streptomyces actuosus. As the result of the addition of factor A to blocked mutants of Streptomyces griseus JA 5142, the synthesis of anthracyclines and leukaemomycin (anthracycline type antibiotic) was resumed. The resistance to streptomycin linked with an enzymatic phosphorylation of the antibiotic is also induced by factor A.

Analogues of factor A have also been found, all of them being gamma-butyrolactones. Virginiae butanolides were detected in Streptomyces virginiae. Factor I was isolated from Streptomyces sp. FR1-5 and its effective concentration was 0.6 ng/ml culture. Most of the factor A analogues, however, were not biologically active.B was isolated from the yeast Saccharomyces cerevisiae. This substance was capable of eliciting the production of rifamycin in a blocked mutant of Nocardia sp. This substance was effective at a concentration of 10-8 M, when one molecule elicited a synthesis of about 1500 molecules of the antibiotic. The structure of factor B is similar to cAMP but none of the derivatives of known nucleotides exhibited a comparable effect. Chemically prepared derivatives of factor B have also been tested. The effect was observed with those that had a C2 -C12 acyl moiety; octylester was the most effective of them, exhibiting the effect at as low a concentration as 10-10 M. A substitution of guanosine for adenine did not result in a loss of the biological activity of factor B. C was isolated from the fermentation medium of Streptomyces griseus. This compound causes cytodifferentiation of non-differentiating mutants . Factor C is a protein having a molecular weight of about 34 500 D, whose molecule is rich in hydrophobic amino acids. The effect of autoregulators is easily observable, if they elicit morphological changes, such as the formation of aerial mycelium. Carbazomycinal and 6-methoxcarbazomycinal, isolated from Streptoverticillium species, were capable of inhibition of the aerial mycelium formation at a concentration of 0.5 to 1 microgram per ml. Autoregulators affecting sporulation were found in Streptomyces venezuelae, Streptomyces avermitilis), and Streptomyces viridochromogenes NRRL B-1551. From the same strain of Streptomyces viridochromogenes, germicidin was isolated by Petersen and co-workers [21]. The compound had an inhibitory effect on the germination of arthrospores of Streptomyces viridochromogenes at a concentration as low as 40 picograms per ml. Germicidin (6-(2-butyl)-3-ethyl-4-hydroxy-2-pyrone) is the first known autoregulative inhibitor of spore germination in the genus Streptomyces and was isolated from the supernatant of germinated spores, but also from the supernatant of a submerged culture.Mutants of Streptomyces cinnamonensis resistant to high concentrations of butyrate and isobutyrate produce an anti-isobutyrate factor, that is excreted into the culture medium . On plates, anti-isobutyrate factor efficiently counteracted toxic concentrations of isobutyrate, acetate, propionate, butyrate, 2-methylbutyrate, valerate, and isovalerate in Streptomyces cinnamonensis and other Streptomyces species.General control mechanisms have been looked for that operate in the antibiotic biosynthesis. The energetic state of the cell is thought to be such a general control mechanism. The intracellular ATP level reflects the content of free energy in the cell. In some cases, the start of the antibiotic synthesis is linked with a decrease of the intracellular ATP level. Such a relationship was observed in Streptomyces aureofaciens and Streptomyces fradiae during the production of tetracycline and tylosin , respectively.

Even though the regulatory role of ATP cannot be strictly excluded, the results seem to support a hypothesis that a higher ATP level is accompanying the active primary metabolism. A slow down of growth and of the whole primary metabolism would logically be accompanied by a decrease of the ATP the case of ATP, the role of cAMP in the metabolism of antibiotic producers was also studied, especially in connection with the glucose regulation. Hitherto, no indication has been obtained suggesting a significant role of cAMP in the regulation of antibiotic production .

antibiotic medicine microorganisms

1.2.3 Reception of signals from environment

The way of reception of signals from the environment, so that they would be available to the genetic material of the cell to result in the initiation of the antibiotic synthesis, is known quite well. It does not significantly differ from the trasduction of signals for other metabolic processes. Catabolite repression signals or those signalling the depletion of nitrogen or phosphate or the initiation of sporulation are transducted via two-component, signal proteins [22]. In spite of some structural varieties, these proteins are characterized by general mechanistic features and conserved amino acid sequences. The two-component system consists of a cytoplasmic membrane-linked, sensor-transmitter protein and a response-regulator protein, located in the cytoplasm. The sensor-transmitter is composed of a sensor domain located near its N-end; the N-end is found outside the cytoplasm. A specific effector is capable of binding directly to this N-end. The transmitter domain is located in the cytoplasm to be linked to the sensor domain via a hydrophobic, amino acid sequence stretching across the membrane. The sensor-transmitter proteins are normal histidine-protein kinases, capable of autophosphorylation at its C-end on receiving a proper signal.

Transcription initiation of structural genes.Regulatory proteins, having been bound to specific DNA sequences and having interacted with RNA polymerase, start the transcription. Regulatory proteins that activate the transcription of structural genes are probably synthesized already during the lag phase. Their binding to DNA and a subsequent biosynthesis of the antibiotic depend mainly on the composition of the growth medium. Provided inorganic phosphate is present in the medium, the activator becomes phosphorylated and thus incapable of binding to DNA. In contrast, for example, the activator of the synthesis of glutamine synthetase, a key enzyme of the assimilation of ammonium salts from the medium and, consequently, of utmost importance for proteosynthesis, is able to bind to DNA only in a phosphorylated form.

One can hypothesize that a depletion of inorganic phosphate from the medium does not stop proteosynthesis as a result of a lack of phosphate in the cell for the biosynthesis of cellular structures, as the phosphate limitation is normally explained, but rather the presence or absence of phosphate in the medium causes respective activation or repression of the activators of the enzyme syntheses in primary or secondary metabolisms.

This idea is also supported by the fact that enzymes of secondary metabolism were synthesized and the antibiotics produced immediately after the phosphate, that had been added at the beginning of the production phase, was depleted from the medium and deposited in the cell [23].

.3 Technology of antibiotic production

Some antibiotics are commercially produced on a ton scale. The fermentation process during which microorganisms produce antibiotics is carried out in fermentors having a volume of several tens of cubic meters. As in any fermentation process, a conserved strain is used, that is first propagated in the laboratory and then in a plant fermentor. The cells are then used to inoculate production fermentors. The inoculum is most often put into a 10 to 20-fold volume of the fresh medium.

Isolation of a producing microorganism from one cell.The spores are transferred from an agar slope into a volume of 10 ml of sterile H2O and, after homogenization, the suspension is diluted to contain 30-50 spores in 1 ml. A volume of 0.25 ml of this suspension is transferred on the surface of a suitable agar medium on a Petri dish and spread with a sterile glass stick. Colonies, each of which originates from one cell, grow on the agar. The individual colonies are re-inoculated to agar slopes and their antibiotic production is tested.

.3.1 Conservation of microorganisms

If cultures are conserved for a long time on agar slopes, being repeatedly transferred from one slope to another, they can degenerate and lose valuable technological properties. Two types of conservation are recommended for long term storage of strains: lyophilization (microbial cells or spores are conserved by quick removal of water by sublimation at a low temperature) or conservation by keeping cultures at a very low temperature (-70oC) in liquid nitrogen. In both cases cultures keep their properties for at least 10 years.

Laboratory cultivation.Cultivation in the laboratory, irrespective of the fact whether the microorganism will finally be used for inoculation of a production fermentor or in laboratory experiments, is carried out in test tubes or in 200-1000-ml bottles and flasks. The volume of the culture medium mostly represents about one tenth of the total volume of the flask. The flasks are sealed with stoppers allowing diffusion of the air into the flasks to ensure aerobic conditions for growth. At the same time, the stoppers prevent microorganisms from the environment to penetrate into the flasks (cotton-wool stoppers, etc.). Producers of antibiotics require a proper aeration, that is important for both the growth and production of the antibiotic. Therefore, the flask contents is well mixed by agitation on rotary or reciprocal shakers placed in thermostated rooms or boxes. Strictly sterile conditions have to be ensured for the cultivation of antibiotic producers since, in the case of contamination, the producing culture can be suppressed by more rapidly growing fermentors.Microbial producers of antibiotics are cultivated in fermentors of various size. The lower limit of size of laboratory fermentors is about 1 litre. Owing to the use of complex media, foam is often formed during cultivation and, therefore, the fermentors are filled with the medium up to one half or two thirds of their maximal capacity. When the process of antibiotic production is scaled up from the laboratory conditions to those of true production, basic parameters can be established using several-litre, laboratory fermentors. However, they should be verified in pilot plant fermentors having a size of several cubic meters. The basic equipment of both laboratory and pilot plant fermentors is practically the same. They are made of inert materials such as glass and stainless steel, or their walls are at least lined with an inert material. The fermentors are equipped with a device keeping the cultivation temperature constant (mainly cooling device is important in large fermentors) and with an efficient aeration system, since antibiotic producers require a sufficient oxygen supply for both the growth and synthesis of the antibiotic. The aeration systems based on intensive stirring are not suitable for cultivation of antibiotic producers since a majority of them are filamentous microorganisms that can suffer damage when intensively stirred. The air flowing into the fermentor has to be sterile. It is sterilized by filtration; most often glass wool or mineral wool filters are used.

Most antibiotics are produced in a fed batch system, i.e. a certain amount of the culture medium is inoculated with the producing microorganism and, after a time interval, another dose of nutrients is added to the fermentor. Thus a prolonged cultivation can be accomplished that enables us to increase the yield of the antibiotic. The inflow of nutrients makes possible keep their optimal levels. In cultivations whose course is well known, the nutrient inflow is programmed in advance.

Solid-state fermentation.Solid-state, or substrate, fermentation is characterized by a fermentation process on a solid support, which has a low moistre content and occurs in a non-septic and natural state [24]. The use of solid-state technology for the production of antibiotics has some advantages. Due to the lack of free water, smaller fermentors are required and the mycelial microorganisms, used predominantely for antibiotic production are well suited to grow on a solid support. On the contrary, a liquid fermentation process allows greater control and monitoring of parameters, such pH, heat, nutrient condition etc [25].

1.3.2 Isolation, separation and purification of antibiotics

Isolation of an antibiotic from the fermentation medium depends on the fact whether the antibiotic is secreted into the medium or remains in the biomass, inside the cell or bound to the cell wall. If the antibiotic is bound to the biomass or, in contrast, present in the broth supernatant, the two phases are separated by filtration or centrifugation and extracted separately. If the antibiotic is present in both phases the whole broth is used for extraction. Another isolation step usually includes an extraction with solvents of different polarities, followed by evaporation of the extracts to dryness. If the antibiotic is extractable by nonpolar solvents, the extraction is preceded by dehydration, most often using methanol or acetone. By the extraction with nonpolar solvents, a most part of water soluble compounds present in the medium is eliminated. The crude isolate obtained is used as a material for further separation processes.antibiotic producers often synthesize a number of compounds or derivatives of the desired compound that have to be separated from the antibiotic produced. The separation is carried out using standard operations such as an extraction into another solvent, chromatography techniques and, in the end, precipitation or crystallization.

2. Experemental part

Streptomyces violatus showed the highest antimicrobial activity in static cultures after 7 days incubation at 30°C. The antibacterial substance was more active against Bacillus subtilis and Staphyllococcus aureus than Escherichia coli or Sarcina lutea. Growth of S. violatus and production of antibiotic in a starch-nitrate medium were monitored over a period of 14 days. The organism produced a blue pigment associated with the antibiotic appearance in the cultures. Optimization of antibiotic production in batch cultures has been carried out. Substitution of starch by glycerol at a concentration of 12.5 g/l showed 1.32-fold increase of antibiotic production. Cultures containing sodium nitrate (2.5g/l) showed the highest antibiotic production followed by peptone, alanine, monosodium glutamate or phenylalanine. A mixture (w/w) of K2HPO4 and KH2PO4 (1g/l) yielded 1.9-fold and 6.1-fold increase in antibiotic production compared to cultures individually supplied with K2HPO4 or KH2PO4, respectively. The presence of ferrous sulphate and manganese chloride improved the production of the antibiotic. An inoculum size of 4x106 spores/ml and initial pH 7.0 at 30°C were optimum for a maximum antibiotic production of 268µg/ml in the culture filtrates of S. violatus [26].

2.1 Abstract to Streptomyces violatus

are the source of several useful antibiotics that are used not only in the treatment of various human and animal diseases but also in agriculture and biochemistry as metabolic poisons .At least 70 of the approximately 100 marketed antibitics used for the treatment of infections in humans are derived from substances produced by Streptomyces spp., for example Streptomyces aureofaciens is an important industrial microorganism as a producer of chlortetracycline and tetracycline. Discovery of new antibiotics produced by streptomycetes still continues, such as noboritomicins A and B produced by S. Noboritoensis [27], actinomycins X2 produced by S. nasri (El-Naggar et al. 1998), tetrodecamycin produced by S. nashvillensis MJ885-mF8, demethyltetracycline produced by S. aureofaciens and pyrroindomycins produced by S. rugosporus (Abbanat et al. 1999). The ability of streptomycete cultures to form antibiotics is not a fixed property but can be greatly increased or completely lost under different conditions of nutrition and cultivation (Waksman 1961). Therefore, the medium constitution together with the metabolic capacity of the producing organism greatly affects antibiotic biosynthesis. Changes in the nature and type of carbon, nitrogen or phosphate sources and trace elements have been reported to affect antibiotic biosynthesis in streptomycetes . In addition, antibiotic productivity tendes to decrease when metal ion deficient media are used and when the inocula are incubated for long periods and at high temperatures. The present study describes the production of an antimicrobial substance MSW2000 produced by a local isolate of Streptomyces violatus. Improvement of antibiotic production was acheived by optimization of the cultural conditions and by developing of a defined medium for the biosynthesis of the antibiotic.

.1.1 Producer of experimentorientalis, S. violatus, S.craterifer and S. astreogriseus were isolated from garden soil, Faculty of Science, Alexandria, Egypt. Soil samples were collected at a depth of 5-10 cm. These strains were identified according to the International Streptomyces Project (ISP) [28].organisms: The following test organisms were used for the bioassay of the antibiotic during the screening experiment: Staphylococcus aureus (209 P FDA), Sarcina leutea (NCIB 495), Bacillus subtilis (ATCC 6051), Escherichia coli (NCIB 1186) and Klepsiella pneumonia (Local isolate). S. aureus was used as a target organism in all other experiments. of Streptomyces violatus for antibiotic production: For studies of antibiotic production, starch-nitrate medium was used as a basal medium. It was composed of (g/l): Starch, 10.0, NaNO3 , 2.5, K2HPO4, 1.0, KH2PO4,1.0 , MgSO4.7H2O, 0.5, KCl, 0.5, trace salt solution 1.0 ml (CuSO4.5H2O (0.64 g/l), FeSO4.7H2O (0.11 g/l), MnCl2.4H2O (0.79 g/l) and ZnSO4.7H2O (0.15 g/l), distilled water,1.0 litre. Medium pH was adjusted to 7.0 before autoclaving using 0.1N NaOH or 0.1 N HCl solution. Fifty-ml aliquots of this medium were dispensed in 250 ml Erlenmeyer flasks. The medium was adjusted to pH 7.0 and sterilised at 121o C for 20 min. Each flask was inoculated with 1.0 ml S. violatus spore suspension obtained from a 6-day-old slant culture. The flasks were then incubated under static conditions at 30o C for 7 days. The antibiotic bioassay was carried out at the end of the incubation period.of dry weight: The cells were separated from the culture filtrate by at 5,000 rpm for 15 minutes, washed twice with distilled water and then dried at 70o C until reaching a constant weight. Preparation of the crude antibiotic: Following 7 day incubation period, S. Violatus cells were separated from the culture by centrifugation at 5,000 rpm for 15 minutes in a cooling centrifuge at 4o C (Chilspin centrifuge MSE Fisons). The blue-coloured clear supernatant was then tested for its antibiotic activity.bioassay: This was carried out using the paper-disc diffusion method, Hinton agar as an assay medium and S. aureus as a test organism. The Mueller-Hinton agar (45o C) was poured into sterile Petri-dishes (9 cm diameter) and allowed to solidify. 0.1 ml bacterial suspension (3 x 106 cells) of the test organism was inoculated into the agar surface. Sterile paper discs (6.0 mm diameter Whatman antibiotic assay discs) were placed on the dried surface of the medium using alcohol-flame-sterilised forceps. Each disc received 20 µl of the culture filtrate. Petri-dishes were kept in a refrigerator for 2 hours to allow for the diffusion of the antibiotic. Petri-dishes were then incubated inverted for 18-24 hours at 37o C. The inhibition zone diameter was measured in mm (Amade et al. 1994). The antibiotic concentration (µg/ml) was determined using a standard calibration curve using the purified antimicrobial substance (MSW2000) produced by S. violatus (Said 2001). estimation: The blue pigment concentration in the culture broth was estimated colorimetrically at 566 nm. This wave length was selected since it showed a maximum absorption of the coloured supernatant measured in UV VIS 4B Spectrophotometer. Each experiment in this work was repeated three times and the average of the three replicates was taken.

.2 Results and discusion

of some locally isolated actinomycetes for the production of antibiotic(s). A survey of four locally isolated Streptomyces strains for antibiotic production was carried out in static and shaken cultures (Table 1). It was generally observed that the growth and antibacterial activity obtained in static cultutres were higher than shaken cultures. Streptomyces astreogriseus showed the longest incubation time (12 days) needed to obtain maximum antibacterial activity, while Streptomyces violatus showed a relatively short time (7-days) and produced the highest activity among the tested strains. Streptomyces violatus was also characterised by its broader antibacterial activity, because it affected the growth of all the tested bacteria, showing a stronger activity on S. aureus and B. subtilis. Accordingly, S. violatus was selected for further investigation.

1 - Screening for the antibacterial activity of Streptomyces strains in static (St) and shaken (Sh) cultures.

growth of S. violatus and the production of antibiotic in a starch-nitrate medium were monitored over a period of 14 days (Fig. 1). The antibiotic production by S. violatus occurred in a growth-phase dependent manner and the highest antibiotic yield was obtained in the late exponential phase and the stationary phase, indicating that it is mainly a product of secondary metabolism. Similar results were observed for streptomycin production in batch cultures of S. griseus [29] when grown in a mineral medium and for the production of candicidin in liquid grown cultures of S. Griseus.The results also showed that S. violatus produced a blue pigment associated with the antibiotic appearance in the culture. It was noticed that a direct tight relationship occurred between the antibiotic production and the intensity of the blue colour formed in the culture (r=0.95). These results may suggest the production of a pigmented antibiotic in S. violatus cultures. The production of the blue-pigmented antibiotic actinorhodin and its physiology are known in S. coelicolor cultures.

1. Effect of different incubation periods on the production of antibiotic by Streptomyces violatus.

2.2.1 Influence of some cultivation factors on the production of antibioticof antibiotic production in batch cultures of S. violatus was carried out. This strain was able to grow in all the tested carbon sources (Table 2). However, maximum antibiotic production was obtained in cultures supplemented with glycerol as a sole carbon source followed by cultures containing starch. Cultures containing fructose, maltose, xylose or cellulose did not yield any detectable amounts of the antibiotic. The results also showed that the increase of glycerol level in the culture from 10g/l to 12.5 g/l led to 1.32-fold increase in antibiotic production (Fig 2). The utilisation of glycerol and starch by S. violatus for growth and production of the antibiotic indicates the presence of an active uptake system for these substrates. Glycerol was also found to be used as a sole carbon source by other Streptomyces species.

2. Effect of glycerol concentration on the production of antibiotic byStreptomyces violatus at different incubation periods: a) 4 days, b) 7 days and c) 10 days.

2 - Effect of different carbon sources on the production of antibiotic by S. violatus.

.2.2 Influence of nitrogen source results revealed that the level of antibiotic production may be greatly influenced by the nature, type and concentration of the nitrogen source supplied in the culture medoium (Table 3). Similar observations have been reported by many investigators. The highest antibiotic production was obtained in cultures of S. Violatus containing sodium nitrate or potassium nitrate as a nitrogen source, followed by cultures containing peptone, alanine, monosodium glutamate or phenylalanine. However, cultures containing asparagine or ammonium citrate did not yield any antibiotic activity and showed lowest growth. The results also showed that the concentration of NaNO3 (Fig. 3) greatly influenced the production of the antibiotic by S. violatus cultures, while the maximum antibiotic yield was obtained in cultures suplemented with 2.5 g/l NaNO3. These results are in partial agreement with those of other investigators. A negative effect of asparagine on the production of cephamycin C was also observed on cultures of S. cattleya, S. latamdurans and Cephalosporium acremonium.

Figure 3. Effect of sodium nitrate (NaNO 3) concentration on the production of antibiotic by Streptomyces violatus at different incubation periods: a) 4 days, b) 7 days and c) 10 days.

3 - Effect of different nitrogen sources on the production of antibiotic by S. violatus.

2.2.3 Influence of potassium phosphate and magnesium sulphate salts is a major factor in the synthesis of a wide range of antibiotics. However, an excessive amount of inorganic phosphate suppresses the production of antibiotics such as tetracycline, actinomycin and candicidin (Kishimoto et al. 1996). The results of the present work (Fig 4) showed that KH2PO4 was not favourable for the production of antibiotic by S. violatus, while K2HPO4 at a concentration of 1g/l yieldes an inhibition zone of 22 mm, equivalent to an antibiotic concentration of 128 µg/ml. It was also observed that addition of a mixture of both phosphate salts (KH2PO4 and K2HPO4) showed the most positive effect on the production of antibiotic by S. violatus. The antibiotic concentration reached its maximum value (245µg/ml) when using a phosphate salt mixture of 1g/l, showing a 1.9-fold and 6.1-fold increase when compared to the highest values obtained when K2HPO4 and KH2PO4 were individually supplied to the medium, respectively. These results are in agreement with those reported by other investigators. The results also showed that addition of 0.5g/l magnesium sulphate to the culture medium was optimal for the production of a maximum yield of antibiotic by S. violatus (Fig 5). At this MgSO4.7H2O concentration, the antibiotic yield was 4.2-fold than that in cultures devoid of magnesium sulphate. The importance of magnesium sulphate for antibiotic production by other Streptomyces species has been reported by several investigators . The effects of magnesium availability are presumably due to requirements of this cation for protein synthesis, and its depletion may restrict enzyme synthesis and activity.

4. Effect of different (a) KH2PO4 and (b) K2HPO4 concentrations on the production of antibiotic by Streptomyces violatus.

results also showed that addition of 0.5g/l magnesium sulphate to the culture medium was optimal for the production of a maximum yield of antibiotic by S. violatus (Fig 5). At this MgSO4.7H2O concentration, the antibiotic yield was 4.2-fold than that in cultures devoid of magnesium sulphate. The importance of magnesium sulphate for antibiotic production by other Streptomyces species has been reported by several investigators. The effects of magnesium availability are presumably due to requirements of this cation for protein synthesis, and its depletion may restrict enzyme synthesis and activity (Aasen et al. 1992; mNatsume et al. 1994).

5. Effect of (MgSO4 .7H2O) concentration on the production of antibiotic by Streptomyces violatus.

.2.4 Influence of trace elements results given in Table 4 showed that iron and manganese could play an important role in the promotion of antibiotic production, the highest dry weight (3.8 mg/ml) was also recorded for manganese. A slight increase in the antibiotic concentration was recorded for Cu, whereas Zn addition lowered the antibiotic concentration compared to the control. The highest antibiotic concentration was achieved in the presence of all elements in the culture medium, yielding a 2.1-fold increase compared to the control reported on the importance of ferrous ions for the growth and antibiotic production by Streptoverticillium rimofaciens. Mansour et al.[30]showed that manganese ions enhanced growth and granaticin production in S. violaceolatus.

Table 4 - The role of trace elements on the production of antibiotic by S. violatus.

3. Protection of workers and life safety

In modern conditions of development of production of a problem in the field of industrial and ecological safety tend to an aggravation. Relevance of a problem of safety of the person and environment is especially sharply shown directly at the enterprises when carrying out technological processes. On trebitel of medicines are interested in receiving qualitative and safe preparations. The workers who are carrying out technological process have to have optimum working conditions.

The main gas emissions in the atmosphere of the enterprises for production of antibiotics containing harmful substances include, except air emissions of all-exchange and local ventilation, technological air emissions at biosynthesis of antibiotics, emissions of boiler and some other auxiliary productions. Various ways of cleaning provide catching about 60% of the harmful substances departing from all sources of pollution.harmful substances consist generally of carbon monoxide (77,4%), sulphurous gas (15,2%) and nitrogen oxides (7,4%).of organic solvents making 24,3% of total amount of the thrown-out substances (tab. 3) belong to liquid and gaseous products, specific to production of antibiotics.Besides, at air emissions there is a number of impurity of vapors of various substances making 0,4% of total amount of the liquid and gaseous products released into the atmosphere. Among them chloride hydrogen, vapors of hydrochloric acid, formaldehyde and prevails.substances, nonspecific for production of antibiotics, in emissions are caught by gas-and-dust cleaning installations for 90%, gaseous emissions of boiler rooms dissipate by means of high pipes. Specific to production of antibiotics firm substances from air emissions for 92,5%, organic solvents - for 10%, 5,4% of the volume of air emissions at biosynthesis of antibiotics are neutralized.

In rooms of storage of finished goods, collecting condensate, preliminary processing of barrels, pump station of reverse water supply, the foreman, the supervising foreman the all-exchange supply and exhaust ventilation is provided. Supply of stitched air and removal of the exhaust is carried out from the top zone, for rooms of packaging of ointment - from the lower zone. In the stitched P-1 installation external air is cleared of dust in the filter 3 classes, warmed up in the superficial heat exchanger and moistened during the cold period of year, during the warm period - is only cleared of dust.

Thus, this system of ventilation of air is effective since provides necessary parameters of air for technological process, favorable microclimatic conditions, deletes harmful substances from air of a working zone.

4. Ecological conservation

Ecological factors influencing the effects of antibiotic production were explored experimentally and theoretically. A spatially structured model was used to model the dynamics of antibiotic-producing and nonproducing bacteria in which growth of the nonproducers was reduced by neighbouring antibiotic producers. Various factors affecting spatial interactions between the bacteria were examined for their impact on antibiotic producers. Spatial clustering had a positive impact on the effect of antibiotic production, as measured by the decline in growth of the nonproducing strain, while increasing the initial density of the nonproducing strain had a negative impact. Experiments examined the growth of antibiotic-producing Streptomyces species and a nonproducing, antibiotic-sensitive strain of Bacillus subtilis that were coinoculated on surface media. There was an effect of the Streptomyces on Bacillus growth in some experiments but not in others. In light of the predictions from the model, unintentional clustering of cells is a more likely explanation for this finding than different initial Bacillus densities. The importance of spatial structure seen in this study is consistent with a terrestrial rather than an aquatic distribution of antibiotic-producing bacteria, and may have implications in the search for novel antibiotics.

Over the last 40 years, there has been a steady supply of novel, useful antibiotics produced by microbes isolated from soil and other natural environments. The increased efficiency of screening procedures in the last decade has played a major part in maintaining this supply. However, the selection and sampling of natural environments are still essentially random processes. The main reasons for this are an almost total lack of knowledge of the significance of antibiotics in nature, deficiencies in the taxonomy of antibiotic-producing microbes and its application, and lack of information about the distribution and ecology of known or potential antibiotic producers. The origins of these problems are discussed and some possible solutions are suggested.

A new perspective on the topic of antibiotic resistance is beginning to emerge based on a broader evolutionary and ecological understanding rather than from the traditional boundaries of clinical research of antibiotic-resistant bacterial pathogens. Phylogenetic insights into the evolution and diversity of several antibiotic resistance genes suggest that at least some of these genes have a long evolutionary history of diversification that began well before the antibiotic era. Besides, there is no indication that lateral gene transfer from antibiotic-producing bacteria has played any significant role in shaping the pool of antibiotic resistance genes in clinically relevant and commensal bacteria. Most likely, the primary antibiotic resistance gene pool originated and diversified within the environmental bacterial communities, from which the genes were mobilized and penetrated into taxonomically and ecologically distant bacterial populations, including pathogens. Dissemination and penetration of antibiotic resistance genes from antibiotic producers were less significant and essentially limited to other high G+C bacteria.


Antibiotics are biotechnological products that inhibit bacterial growth or kill bacteria. They are naturally produced by microorganisms, such as fungi, to attain an advantage over bacterial populations <>. Antibiotics are produced on a large scale by cultivating and manipulating fungal cells. Many antibacterial compounds are classified on the basis of their chemical or biosynthetic origin into natural, semisynthetic, and synthetic. Another classification system is based on biological activity. In this classification, antibiotics are divided into two broad groups according to their biological effect on microorganisms: bactericidal <> agents kill bacteria, and bacteriostatic <> agents slow down or stall bacterial growth. of some locally isolated actinomycetes for the production of antibiotic(s). A survey of four locally isolated Streptomyces strains for antibiotic production was carried out in static and shaken cultures. It was generally observed that the growth and antibacterial activity obtained in static cultutres were higher than shaken cultures. Streptomyces astreogriseus showed the longest incubation time (12 days) needed to obtain maximum antibacterial activity, while Streptomyces violatus showed a relatively short time (7-days) and produced the highest activity among the tested strains. Streptomyces violatus [30] was also characterised by its broader antibacterial activity, because it affected the growth of all the tested bacteria, showing a stronger activity on S. aureus and B. subtilis. Accordingly, S. violatus was selected for further investigation.Antibiotics are produced industrially by a process of fermentation, where the source microorganism is grown in large containers (100,000-150,000 liters or more) containing a liquid growth medium. Oxygen concentration, temperature, pH <#"justify">References

1 B?hal V. Bioactive products from Streptomyces. Adv Appl Microbiol 2000;47:113-156.

2Omura S, Sasaki Y, Iwari Y and Takeshima H. Staurosporine, a potentially important gift from a microorganism. J Antibiot 1995;48:535-548.

B?hal V. Nontraditional microbial bioactive metabolites. Folia Microbiol 2001;46: (6) 000-000, (in press).

4 Umezawa K, Aoyagi T, Suda T, Hamada M and Takeuchi T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot 1976;30:170-173.

Bennett JW and Bentley R. What is a name?-Microbial secondary metabolites. Adv Appl Microbiol 1989;35:1-28.

6 Lipman F. Attempts to map a prcoess evolution of peptide biosynthesis. Science 1971;173:875-884.

7 Laland SG and Zimmer T-L. Bioactive peptides produced by microorganisms. Essay Biochem 1973;9:31-57.

8 Ohno A, Ano T and Shoda M. Production of the antifungal peptide antibiotic, iturin, by Bacillus subtilis NB 22 using wheat bran as a substrate. Biotechnol Lett 1992;14:817-822.

Billich A and Zocher R. Enzymatic synthesie of cyclosporine A. J Biol Chem 1987;262:17258-17259.

10 B?hal V and Hunter IS. In: Vining LC and Stuttard C (eds) Genetics and Biochemistry of Antibiotics Production. Butterworth-Heinemann, Boston, 1995;359-384.

11 Kleinkauf H von Doehren H In: Kleinkauf H., von Doehren H, Dornauer H and Nasemann G (eds) Regulation of Secondary Metabolite Formation, VCH Verlagsgesselshaft, Weinheim, 1986:173-207.

12 Roland I, Froyshov O and Laland G. A rapid method for the preparation of three enzymes of bacitracin synthetase essentialy free from other proteins. FEBS Lett 1977;84:22-24.

13 Ishihara HM, Hara N and Iwabuchi T. Molecular cloning and expression in Escherichia coli of Bacillus licheniformis bacitracin synthetase gene 2 gene. J Bacteriol 1989;171: 1705-1711.

14 von Doehren H. In: Vining LC and Stuttard C (eds) Genetics and Biochemistry of Antibiotic Production, Butterworth-Heinemann, Boston, 1995;129-171.

15 Martin JF and Liras P. Beta-lactams. Adv Biochem Eng 1989;39:153-187.

Jensen SE and Demain AL. In: Vining LC and Stuttard C (eds) Genetics and Biochemistry of Antibiotics Production, Butterworth-Heinemann, Boston, 1995;239-268.

17 Newton GGF and Abraham EP. Isolation of cephalosporin C, penicillin-like antibiotic containing D-?-aminoadipic acid. Biochem J 1956;62:651-658.

18 Martin JF. ?-aminoadipyl-cysteinyl-valine santhetases in ?-lactam producing organisms. J Antibiot 2000;53:1008-1021.

19 Abraham EP. In: Kleinkauf H, von Doehren H, Dornauer H and Nesemann G (eds) Regulation of secondary metabolite formation. VCH Verlagegesselshaft, Weinheim, 1986;115-132.

20 Parenti F and Cavalleri B. Proposal to name the vancomycin-ristoceti like glycopeptides as dalbaheptides. J Antibiot 1989;42:1882-1883.

21 Williams DH, Stone MJ, Mortishire-Smith RJ and Hauck PR. Molecular recognition by secondary metabolites. Biochem Pharmacol 1990;40:27-34.

22 Bentley R and Bennett JW. Constructinc polyketides: From Collie to combinatorial biosynthesis. Ann Rev Microbiol 1999;53:411-446.

23 Hopwood DA and Sherman DH. Molecular genetic of polyketides and its comparison to fatty acid biosynthesis. Ann Rev Genet 1990;14:37-66.

24 Dimroth P, Walter H and Lynen F. Biosynthesis von 6-methylsalicylsaure. Eur J Biochem 1970;13:98-110.

25 Dimroth P, Ringelmann E and Lynen F. 6-methylsalicylic acid from Penicillium patulum. Eur J Biochem 1976;68: 591-596.

26 Aasen IM, Folkvord K & Levine DW (1992) Development of a process for large- scale chromatographic purification of an alginate lyase from Klebsiella pneumoniae. Journal of Applied Microbiology and Biotechnology 37: 55-60.

27 Bibb M (1996) The regulation of antibiotic Production in Streptomyces coelicolor A3(2). Microbiology 142: 1335-1344.

28 Bystrykh LV, Fernander-Moreno M A, Herrema J K, Malportida F, Hopwood D A & Dijkhuizen L (1996) Production of actinorhodin-related blue pigments by Streptomyces coelicolor A3(2). Journal of Bacteriology 178: 2238-2244.

29 Hobbs G, Catherine M, Frazer C, David CJ, Gardner FF & Oliver, SG (1990) Pigmented antibiotic production by Streptomyces coelicolor A3(2): Kinetics and the influence of nutrients. Journal of General Microbiology 136: 2291-2296.

30 Said WY (2001) Production of antibiotics by immobilized Streptomyces strains. Ph.D. Thesis, Faculty of Science, Alexandria University, Egypt. 1995;48:535-548.

Теги: Semisynthetic and synthetic antibiotics  Диплом  Медицина, физкультура, здравоохранение
Просмотров: 17358
Найти в Wikkipedia статьи с фразой: Semisynthetic and synthetic antibiotics